Active Ingredient (Per Inhaler)
Levmetamfetamine 50 mg
The following Structured Product Label (SPL) was submitted to the FDA by Aphena Pharma Solutions for the product Nasal Decongestant Inhaler (NDC 54884-050). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (per inhaler), purpose, use for temporary relief of nasal congestion due to:, warnings, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Levmetamfetamine 50 mg
Nasal decongestant
symptoms persist
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
| adults and children 12 years of age and over | 2 inhalations in each nostril |
children 6 to under 12 years of age (with adult supervision) | 1 inhalation in each nostril |
| children under 6 years of age | ask a doctor |
| children under 2 years of age | do not use |
bornyl acetate, camphor, lavender oil, menthol, methyl salicylate
_______________________
NDC 54884-050-01
Aphena Pharma Solutions
Nasal Decongestant Inhaler
Levmetamfetamine
_______________________
Levmetamfetamine 50mg - Nasal Decongestant
Use for temporary relief of nasal decongestion
due to:
• the common cold
• hay fever or upper respiratory allergies
Net Wt 0.007 OZ (198 mg) Per Inhaler See Drug Facts
* Please review the disclaimer below.